In conclusion, EGF and Lipocalin-2/NGAL proteins specifically associated with renal inflammation are reliable biomarkers for assessing chronic kidney disorders, and should be considered in studies looking at DKD and LN disease progression. Here, LCN2 is linked to diabetic kidney disease.